FDA Grants Orphan Drug Status to Soligenix's MarVax™: A Turning Point in Marburg Virus Prophylaxis.
undefined subscriptions will be displayed on your profile (edit)
Skip for now
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to sign in.
Share this post
Health Company Granted FDA Orphan Drug Status…
Share this post
FDA Grants Orphan Drug Status to Soligenix's MarVax™: A Turning Point in Marburg Virus Prophylaxis.